Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
1.
Immunol Rev ; 182: 215-27, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11722637

ABSTRACT

Notch signalling plays a critical role in embryogenesis, influencing the differentiation and growth of a variety of cell types across the species. In the mammalian immune system, Notch signalling operates at various levels; it controls the differentiation of haematopoietic stem cells and directs the early development of the T and B-cell lineages. It is also involved in the maturation of both CD4+ and CD8+ T cells in the thymus. The biological activities of this pathway extend beyond lymphocyte ontogeny; recent evidence has shown that it also contributes to the regulation of the peripheral immune system through its ability to influence cell survival and growth. In fulfilling this function, Notch signalling appears to act in conjunction with defined immunological signals such as cytokines, T-cell antigen receptor and co-stimulatory receptor-mediated signalling. In this review we discuss the potential of the Notch signalling pathway in the maintenance of homeostasis within the immune system affecting both peripheral tolerance and the negative feedback controlling productive immunity. The therapeutic manipulation of this pathway is likely to have broad application in a range of immunologically based diseases.


Subject(s)
Immunity , Membrane Proteins/physiology , Signal Transduction , Animals , Cell Differentiation , Cytokines/metabolism , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/immunology , Homeostasis , Immune Tolerance/immunology , Receptors, Notch , T-Lymphocytes/cytology , T-Lymphocytes/immunology
2.
Am J Respir Crit Care Med ; 162(4 Pt 2): S169-74, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11029389

ABSTRACT

Regulatory mechanisms exist in the immune system to limit the induction of pathogenic responses to antigens encountered within the respiratory tract. The development of allergic disease is thought to arise as a result of the breakdown in these regulatory processes. In this review we examine the nature of immune responses generated to inhaled protein antigens and the mechanisms used to establish tolerance to inhaled antigens.


Subject(s)
Antigens/immunology , Immune Tolerance/immunology , Respiratory Hypersensitivity/immunology , Humans , T-Lymphocyte Subsets/immunology
3.
Immunology ; 100(3): 281-8, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10929049

ABSTRACT

Recognition of antigen by T cells in the periphery may lead either to the generation of productive immunity or the induction of tolerance. These two functional outcomes are a consequence of distinct pathways of T-cell differentiation. T cells are selected to become regulatory cells and their function is to maintain homeostasis with the immune system. In this review we discuss the cell-fate decisions that T cells might make allowing them to promote immunity or induce tolerance in the context of the role that Notch signalling may play in this process.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Immune Tolerance , Membrane Proteins/immunology , T-Lymphocyte Subsets/immunology , Animals , Humans , Immunity, Cellular , Mice , Receptors, Notch , Signal Transduction/immunology
4.
Int Immunol ; 12(2): 177-85, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10653853

ABSTRACT

Signals derived from antigen-presenting cells (APC) influence the functional differentiation of CD4(+) T cells. We report here that Serrate1 (Jagged1), a ligand for the Notch1 receptor, may contribute to the differentiation of peripheral CD4(+) T cells into either helper or regulatory cells. Our findings demonstrate that antigen presented by murine APC overexpressing human Serrate1 induces naive peripheral CD4(+) T cells to become regulatory cells. These cells can inhibit primary and secondary immune responses, and transfer antigen-specific tolerance to recipient mice. Our results show that Notch signalling may help explain 'linked' suppression in peripheral tolerance, whereby tolerance induced to one epitope encompasses all epitopes on that antigen during the course of an immune response.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Immune Tolerance , Membrane Proteins/metabolism , Signal Transduction , Animals , Antigen-Presenting Cells/immunology , Antigen-Presenting Cells/metabolism , Antigens, Dermatophagoides , Calcium-Binding Proteins , Cells, Cultured , Epitopes/immunology , Female , Gene Expression Regulation/immunology , Glycoproteins/immunology , Humans , Immunity, Cellular , Immunization , Intercellular Signaling Peptides and Proteins , Jagged-1 Protein , Leukocytes, Mononuclear/immunology , Membrane Proteins/genetics , Mice , Ovalbumin/immunology , Rats , Receptors, Notch , Reverse Transcriptase Polymerase Chain Reaction , Serrate-Jagged Proteins
5.
Int Arch Allergy Immunol ; 118(2-4): 122-4, 1999.
Article in English | MEDLINE | ID: mdl-10224357

ABSTRACT

BACKGROUND: Peripheral tolerance is required to maintain balance within the immune system. A feature of peripheral tolerance is linked suppression, in which tolerance induced to a single T cell epitope inhibits the response to all epitopes in the same protein. It is suggested that this phenomenon is mediated by regulatory T cells through either the activity of immunopressive cytokines or direct cell contact. In previous experiments we failed to detect inhibitory cytokines when T cells from mice rendered tolerant by intranasal delivery of the immunodominant peptide of Der p 1 (p 1, 110-131) were restimulated with peptide in vitro. Therefore, the aim of this study was to determine if cognate interactions between T cells mediated by Notch/Delta signaling induce and maintain peripheral T cell tolerance. METHODS: Using in situ hybridization and viral mediated gene transfer, the expression and function of Delta1 were investigated in a murine model of T cell tolerance to Der p 1 in vivo. RESULTS: Delta1 expression is increased on peripheral T cells during the induction of tolerance with high-dose peptide delivered intranasally and when tolerant animals are rechallenged under immunogenic conditions. Peptide p 1, 110-131-specific CD4+ T cells transfected with Delta1 inhibited the response of antigen-primed T cells and induced linked suppression. CONCLUSIONS: High-dose peptide delivered intranasally induces transient expression of Delta 1 on inhibitory CD4+ T cells. Ligation of the Notch1 receptor on neighbouring T cells by Delta1+ regulatory T cells inhibits clonal expansion of the former and mediates linked suppression.


Subject(s)
Glycoproteins/immunology , Hypersensitivity/immunology , Immune Tolerance , T-Lymphocytes/immunology , Allergens/immunology , Animals , Antigens, Dermatophagoides , Epitope Mapping , Mice , Mice, Inbred C57BL , Mites , Peptide Fragments/immunology
7.
Int Arch Allergy Immunol ; 116(2): 93-102, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9652301

ABSTRACT

Immunological tolerance is defined as a state of specific non-responsiveness to a particular antigen induced by previous exposure to that same antigen. The mucosal surfaces comprise the upper and lower respiratory tracts, the gastrointestinal tract and the urogenitary tract, and are a major site of antigenic challenge. The immune system associated with the mucosa has the extraordinary potential to discriminate between antigens that are harmless (e.g. inhaled and dietary antigens) and those that are associated with pathogens. Normally soluble proteins delivered through the mucosal surfaces do not elicit a strong systemic immune response but instead induce a transient local immune response that is replaced by long-term peripheral unresponsiveness this is termed mucosal tolerance. The phenomenon of oral tolerance is well established and considerable attention has focussed on defining the underlying mechanisms. However, only comparatively recently was the induction of tolerance via the respiratory mucosa described, and it is this form of mucosal tolerance which forms the basis of this review.


Subject(s)
Immune Tolerance/immunology , Respiratory System/immunology , Humans , Nasal Mucosa/immunology , Respiratory Hypersensitivity/immunology , Th1 Cells/immunology , Th2 Cells/immunology
8.
Int Immunol ; 9(8): 1165-73, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9263014

ABSTRACT

Mucosal administration of antigens in experimental animals leads to the induction of peripheral T cell tolerance. We have previously reported that in H-2b mice, intranasal (i.n.) or oral administration of a peptide containing the immunodominant T cell epitope will down-regulate the function of CD4+ T cells reactive with Der P 1, a major target antigen in both B and T cell responses to house dust mite. In the present study we have investigated the tolerogenicity of peptides containing both dominant and subdominant determinants when given i.n. to nalve mice. Induction of tolerance by the nasally administered immunodominant peptide leads to a diminution in all T cell-derived cytokines and modulation of delayed-type hypersensitivity responses, but IgE production did not seem to be affected, furthermore the induction of T cell tolerance was stable, lasting beyond 6 months. We have also examined the specificity of intramolecular epitope suppression which is a feature of mucosal tolerance induced by nasally administered peptides and demonstrate that regulatory CD4+ T cells may exert their suppressive effect by linked recognition of epitopes on the same or neighbouring antigen-presenting cells.


Subject(s)
Clonal Anergy/immunology , Epitopes, T-Lymphocyte/immunology , Glycoproteins/immunology , Glycoproteins/pharmacology , Lymphokines/metabolism , Mites/immunology , Peptides/pharmacology , T-Lymphocytes/drug effects , Administration, Intranasal , Animals , Antigen Presentation/immunology , Antigens, Dermatophagoides , CD4-Positive T-Lymphocytes/immunology , Dose-Response Relationship, Immunologic , Down-Regulation , Mice , Mice, Inbred C57BL , Passive Cutaneous Anaphylaxis , Peptides/administration & dosage , Peptides/chemical synthesis , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
9.
Int J Biochem Cell Biol ; 29(8-9): 1053-7, 1997.
Article in English | MEDLINE | ID: mdl-9416000

ABSTRACT

The cluster of differentiation (CD) antigen CD28 is a 44-kDa, disulphide-bonded, homodimeric glycoprotein, which is constitutively expressed on the surface of all murine T cells and the majority of human T cells. Ligation of CD28 by its counter receptor, B7, expressed on the surface of antigen presenting cells, has been shown to induce signals that, in synergy with those derived from engagement of the T cell receptor by an antigen bound to a major histocompatibility complex, enhance proliferation and cytokine production. Manipulation of this interaction can have dramatic effects on the outcome of T cell activation. Blocking CD28/B7 interactions may be useful in preventing unwanted activation in allergy and autoimmune diseases, whereas enhancing this interaction can promote tumour rejection. Thus, CD28 and its signalling pathways may prove to be useful targets in the development of new therapeutic treatments.


Subject(s)
CD28 Antigens , T-Lymphocytes/immunology , Antigen-Presenting Cells , Autoimmune Diseases/therapy , CD28 Antigens/biosynthesis , CD28 Antigens/chemistry , CD28 Antigens/genetics , CD28 Antigens/immunology , CD28 Antigens/physiology , Gene Expression Regulation , Humans , Hypersensitivity/therapy
10.
Immunol Cell Biol ; 75(2): 197-201, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9107576

ABSTRACT

Administering antigens through mucosal surfaces leads to the induction of antigen-specific T cell unresponsiveness. This property of the mucosal immune system is now beginning to be exploited in the design of immunotherapeutic strategies aimed at targeting disease-inducing T cell populations. The induction of high dose mucosal tolerance leads to the induction of T cell anergy. Recent studies have suggested that the induction of anergy in vivo may not necessarily be due to a lack of costimulation by APC. Instead, recognition of mucosal antigen leads to transient T cell activation which eventually gives rise to a population of regulatory T cells whose function is to modulate, rather than promote antigen-specific immune responses. These regulatory T cells mediate linked suppression in vivo thus enabling T cell responses directed to a multideterminant protein to be effectively controlled. The manner in which T cell responses to mucosally delivered antigens are regulated are examined herein.


Subject(s)
Immune Tolerance , Immunity, Mucosal , T-Lymphocyte Subsets/immunology , Animals , Immune System , Oligopeptides
11.
Int Immunol ; 9(2): 273-80, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9040009

ABSTRACT

The group I (Der p 1) allergen of Dermatophagoides pteronyssinus (house dust mite, HDM) contains several T helper (Th) epitopes recognized by C57BL/6 mice, with the peptide (111-139) containing a dominant MHC class II-restricted epitope (113-127). Since CD8+ T cells are thought to play a role in the regulation of allergic disease, we examined the Der p 1 sequence for potential MHC class I-binding motifs and observed that residues 111-119 (FGISNYCQI) contain motifs for H-2Db and Kb. Furthermore, immunization of C57BL/6 mice with unadjuvanted Ty virus-like particles (VLP) carrying Der p 1 (111-139), a method known to induce murine cytotoxic T lymphocyte (CTL) responses, primed Der p 1 (111-119)-specific Db-restricted CTL which produce high levels of IFN-gamma and low levels of IL-5 and IL-6 in vitro (T1-type CTL). VLP carrying the minimal epitope (FGISNYCQI) also induced a CTL response following immunization without adjuvant by various routes. Der p 1 (111-139)-VLP adjuvanted with alum did not prime CTL in C57BL/6 mice but were found to prime Th1-type CD4+ T cells that recognize the overlapping peptide (113-127) and native protein. The ability to successfully predict allergen-specific CD8+ T cell epitopes and prime CD8+ and/or CD4+ T cell responses provides an opportunity to dissect the relative roles of these T cells in the regulation of allergic responses and may offer therapeutic potential for reprogramming Th2-type allergic responses.


Subject(s)
Allergens/immunology , Glycoproteins/immunology , Immunodominant Epitopes/immunology , Lymphocyte Activation , Mites/immunology , T-Lymphocytes, Cytotoxic/immunology , Th1 Cells/immunology , Administration, Intranasal , Animals , Antigens, Dermatophagoides , CD5 Antigens/immunology , CD8 Antigens/immunology , Cytokines/biosynthesis , Cytotoxicity Tests, Immunologic , Female , Genes, MHC Class I/immunology , Immunodominant Epitopes/classification , Injections, Intramuscular , Injections, Intraperitoneal , Mice , Mice, Inbred C57BL , Spleen/cytology , T-Lymphocytes, Cytotoxic/physiology , Th1 Cells/metabolism
13.
Int Immunol ; 8(7): 1091-8, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8757954

ABSTRACT

In this study we demonstrate that immunization of H-2(b) mice with the allergen Der p 1 induces MHC class II restricted T cells that proliferate to residues 15-29 of Der p 1 (p15-29) and to the murine MHC class II-associated invariant chain derived peptide (CLIP). T cells from naive H-2(b) mice and those immunized with murine CLIP fail to respond to either CLIP or p15-29. T cell lines and clones reactive with p15-29 strongly proliferate in response to splenic antigen-presenting cells (APC) from normal H-2(b) mice but show reduced proliferation to APC from invariant chain deficient mice. Furthermore, T cells isolated from Der p 1 primed mice and expanded on H-2(b) spleen cells in the absence of the p15-29 epitope retained specificity for both p15-29 and CLIP, suggesting that naturally presented self components can act as mimetic peptides and may maintain T cell memory to foreign antigens.


Subject(s)
Allergens/immunology , Antigens, Differentiation, B-Lymphocyte/immunology , Glycoproteins/immunology , Histocompatibility Antigens Class II/immunology , Lymphocyte Activation , Mites/immunology , T-Lymphocytes/immunology , Amino Acid Sequence , Animals , Antigens, CD/immunology , Antigens, Dermatophagoides , Cells, Cultured , Cross Reactions , Female , H-2 Antigens/immunology , Humans , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Sequence Homology, Amino Acid , Vaccination
14.
Immunol Cell Biol ; 74(2): 180-6, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8724007

ABSTRACT

A major key to successful immunotherapy may depend on altering the qualitative nature of the immune response in allergic patients. In this review we examine how immune responses to environmental allergens are regulated, and the mechanisms used by the immune system to prevent allergic sensitization. We also discuss future prospects of using allergen-derived peptides in immunotherapy and the possibility of 'reprogramming' the immune responses by immunizing under conditions that promote Th1 responses instead of Th2 responses.


Subject(s)
Hypersensitivity/immunology , Peptides/immunology , Animals , Desensitization, Immunologic , Forecasting , Humans , Hypersensitivity/therapy , Peptides/therapeutic use
15.
Int Immunol ; 8(3): 335-42, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8671619

ABSTRACT

We have previously demonstrated that intranasal (i.n.) administration of an immunodominant peptide (p1-111-139) derived from the house dust mite (HDM) allergen Der p 1 inhibits antigen-specific CD4+ T cell responses in H-2b mice. Here we report that i.n. peptide induced a rapid but transient activation of MHC class II restricted CD4+ T cells that peaked 4 days after peptide treatment and was of similar magnitude to that induced by parenteral immunization with antigen in adjuvant. During the early phase of the response lymph node and splenic T cells secreted a range of lymphokines when re-stimulated in vitro with p1 111-139; however, by day 14 IL-2 and IFN-gamma secretion by T cells were down-regulated. Mice deficient in CD8+ T cells became tolerant by i.n. treatment with peptide, suggesting that CD8+ T cells are not involved in down-regulating the CD4+ T cell response. Rechallenging mice with a single dose of p1 111-139 21 days after the initial treatment elicited a further transient T cell response, which was subsequently down-regulated over time. Although the i.n. peptide induced a strong transient CD4+ T cell response, only low levels of peptide-specific antibodies were detected either after the initial or subsequent i.n. exposures to p1 111-139. Our findings address the mechanisms underlying peripheral T cell tolerance following i.n. administration of a high dose of immunogenic peptide and have implications for understanding the consequences of peptide immunothearapy.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Glycoproteins/immunology , Immune Tolerance , Animals , Antibodies, Monoclonal/immunology , Antigens, Dermatophagoides , Female , Glycoproteins/administration & dosage , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Histocompatibility Antigens Class II/drug effects , Immunodominant Epitopes , Immunoglobulin G/biosynthesis , Immunoglobulin M/biosynthesis , Interleukin-2/biosynthesis , Interleukin-3/biosynthesis , Lymphocyte Activation , Mice , Mice, Inbred C57BL
16.
Curr Opin Immunol ; 7(6): 757-61, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8679116

ABSTRACT

In vitro peptide stimulation of allergen-reactive T-helper type 1 and type 0 cells, in the absence of costimulatory signals, induces anergy that is accompanied by the modulation of cell surface phenotype and changes in cytokine production. In experimental animal models, the administration of allergen-derived peptides may result in the downregulation of cytokine and antibody production, which is preceded by transient activation of CD4+ T cells, without the induction of effector immunity. Preliminary results of clinical trials using allergen-derived peptides for desensitization are becoming available and should provide some insight into the efficacy of peptide therapy in man.


Subject(s)
Antigenic Modulation , Hypersensitivity, Immediate/immunology , Peptides/immunology , Th1 Cells/immunology , Cytokines/biosynthesis , Desensitization, Immunologic , Epitopes , Humans , Immune Tolerance , Models, Immunological
17.
Int Arch Allergy Immunol ; 107(1-3): 275-7, 1995.
Article in English | MEDLINE | ID: mdl-7613149

ABSTRACT

Quantitative and qualitative characteristics of the signals received by a T cell determine whether receptor ligation results in cell activation, cell death, or the induction of antigen-specific non-responsiveness. Environmental factors such as the nature of costimulation, antigen-presenting cell type, peptide structure and cytokine levels also influence the differentiation of CD4+ helper T cells into functionally distinct subsets, which now appear pivotal in many immune-mediated disorders, including autoimmunity and allergy. Selective manipulation of the immune response, such as the functional inactivation or deviation of the cytokine secretion patterns of specific T cells, may be an effective strategy for immunotherapy.


Subject(s)
Allergens/therapeutic use , Desensitization, Immunologic/methods , Peptide Fragments/therapeutic use , Th1 Cells/immunology , Th2 Cells/immunology , Allergens/immunology , Allergens/pharmacology , Animals , Antigen Presentation , Cats , Cytokines/physiology , Glycoproteins/immunology , Glycoproteins/pharmacology , Glycoproteins/therapeutic use , Humans , Hypersensitivity/immunology , Hypersensitivity/therapy , Immune Tolerance/drug effects , Immune Tolerance/physiology , Mice , Peptide Fragments/immunology , Peptide Fragments/pharmacology , Th1 Cells/drug effects , Th2 Cells/drug effects
18.
Immunology ; 84(2): 304-9, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7751007

ABSTRACT

Mice fed a protein antigen develop a phenomenon called oral tolerance which is defined classically by the inability to respond to a parenteral challenge with the same antigen. In a recent report we showed that antigen-reactive T cells are not depleted following the development of oral tolerance to the soluble antigen ovalbumin (OVA). Instead mice remain highly sensitized so OVA-reactive T cells can be detected in the mesenteric lymph nodes (MLN), Peyer's patches and spleen. In the present study we show that OVA-specific T cells become sensitized in the MLN within 24 hr of feeding and that lymphokine responses peak 48-96 hr after feeding. T cells produced large amounts of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interferon-gamma (IFN-gamma) but no interleukin-2 (IL-2) following activation in vitro. Responsiveness as measured by GM-CSF declined by days 8-11 while the ability to stimulate IFN-gamma secretion was more persistent. It was found in experiments with repeated feeding, 1 week apart, that the T-cell responsiveness was restimulated after each feed and that the magnitude and duration of the IFN-gamma or GM-CSF responses were almost identical to primary, even after 10 feeds.


Subject(s)
Eating/immunology , Immune Tolerance , Lymphokines/biosynthesis , Ovalbumin/administration & dosage , T-Lymphocytes/immunology , Animals , Cells, Cultured , Female , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Immunization , Interferon-gamma/biosynthesis , Kinetics , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymphocyte Activation , Mesentery , Mice , Mice, Inbred BALB C , Ovalbumin/immunology
19.
Immunology ; 83(2): 190-5, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7530688

ABSTRACT

H-2b mice respond to the 222 residue allergen Der p I by producing T cells sensitized to the dominant epitopes encompassed in peptides 21-49, 78-100, 110-131 and 197-212. Immunization with the synthetic peptides 120-143 and 144-169, however, revealed cryptic epitopes which could sensitize T cells for responses to the respective peptides and, providing splenic adherent cells were added to lymph node cultures, to the whole allergen. It is shown that feeding recombinant fusion peptides can markedly inhibit the ability of the whole antigen to immunize mice, as measured by the in vitro interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF)/IL-3 release on stimulation with protein or peptides, although inhibition measured by IL-2 release was more marked. The inhibition extended to epitopes other than those in the fusion peptides used for feeding. Thus feeding peptide 101-154 inhibited responses to 110-131 and 78-100. Fusion peptides 1-14 and 188-222 did not inhibit responses, although 188-222 did contain an epitope. Inhibition was also obtained when mice were fed a fusion containing the cryptic epitope 144-169. The ability of peptides containing the cryptic epitopes to inhibit responses has significant implications for peptide-based immunotherapy.


Subject(s)
Allergens/immunology , Epitopes/immunology , Glycoproteins/immunology , Immune Tolerance/immunology , T-Lymphocytes/immunology , Administration, Oral , Animals , Antigens, Dermatophagoides , Cells, Cultured , Cytokines/biosynthesis , Epitopes/analysis , Mice , Mice, Inbred C57BL , Mites/immunology , Peptide Fragments/administration & dosage , Peptide Fragments/immunology , Recombinant Proteins/immunology
20.
Immunol Cell Biol ; 72(1): 29-33, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8157285

ABSTRACT

Feeding protein antigens to mice normally leads to the development of oral tolerance but under some circumstances, feeding can lead to immunity, for example, following pretreatment of mice with cyclophosphamide (CY). In both cases, however, it is possible to detect sensitized T cells in the spleen and mesenteric lymph nodes (MLN) by in vitro lymphokine release for granulocyte-macrophage-CSF (GM-CSF) and IFN-gamma. This study examines the recognition of the immunodominant T cell epitope on ovalbumin (OVA) following intragastric priming and tolerance. T cells from CY/OVA treated mice and cells from mice injected subcutaneously with OVA in CFA responded well to both OVA and the H2d restricted peptide epitope pOVA323-339 releasing GM-CSF. On the other hand MLN or spleen T cells from tolerized mice which responded to the protein in vitro did not recognize the immunodominant determinant. The cells responding from tolerized mice were restricted by the class II MHC so these results show there can be differential recognition of T cell epitopes between oral priming and tolerance.


Subject(s)
Immune Tolerance , Immunodominant Epitopes/immunology , T-Lymphocytes/immunology , Administration, Oral , Animals , Antigen Presentation , Cells, Cultured , Cyclophosphamide/administration & dosage , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Immunity , Lymph Nodes/cytology , Mice , Mice, Inbred BALB C , Ovalbumin/immunology , Spleen/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...